Sec. 263. Requiring prescribers of controlled substances to complete training
724 words·~3 min read·
/bill/117/hr/7666/rh/section-263A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 303 of the Controlled Substances Act ( 21 U.S.C. 823 ) is amended by adding at the end the following: As a condition on registration under this section to dispense controlled substances in schedule II, III, IV, or V, the Attorney General shall require any qualified practitioner, beginning with the first applicable registration for the practitioner, to meet the following: If the practitioner is a physician, the practitioner meets one or more of the following conditions:
The physician holds a board certification in addiction psychiatry or addiction medicine from the American Board of Medical Specialties. The physician holds a board certification from the American Board of Addiction Medicine. The physician holds a board certification in addiction medicine from the American Osteopathic Association. The physician has, with respect to the treatment and management of patients with opioid or other substance use disorders, completed not less than 8 hours of training (through classroom situations, seminars at professional society meetings, electronic communications, or otherwise) that is provided by— the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, the American Psychiatric Association, or any other organization accredited by the Accreditation Council for Continuing Medical Education (commonly known as the ACCME ); any organization accredited by a State medical society accreditor that is recognized by the ACCME; any organization accredited by the American Osteopathic Association to provide continuing medical education; or any organization approved by the Assistant Secretary for Mental Health and Substance Abuse or the ACCME.
The physician graduated in good standing from an accredited school of allopathic medicine or osteopathic medicine in the United States during the 5-year period immediately preceding the date on which the physician first registers or renews under this section and has successfully completed a comprehensive allopathic or osteopathic medicine curriculum or accredited medical residency that included not less than 8 hours of training on treating and managing patients with opioid and other substance use disorders, including the appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of a substance use disorder.
If the practitioner is not a physician, the practitioner meets one or more of the following conditions: The practitioner has completed not fewer than 8 hours of training with respect to the treatment and management of patients with opioid or other substance use disorders (through classroom situations, seminars at professional society meetings, electronic communications, or otherwise) provided by the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, the American Nurses Credentialing Center, the American Psychiatric Association, the American Association of Nurse Practitioners, the American Academy of Physician Associates, or any other organization approved or accredited by the Assistant Secretary for Mental Health and Substance Abuse or the or the Accreditation Council for Continuing Medical Education.
The practitioner has graduated in good standing from an accredited physician assistant school or accredited school of advanced practice nursing in the United States during the 5-year period immediately preceding the date on which the practitioner first registers or renews under this section and has successfully completed a comprehensive physician assistant or advanced practice nursing curriculum that included not fewer than 8 hours of training on treating and managing patients with opioid and other substance use disorders, including the appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of a substance use disorder.
The Attorney General shall not require any qualified practitioner to complete the training described in clause
(iv)or
(v)of paragraph (1)(A) or clause
(i)or
(ii)of paragraph (1)(B) more than once. Nothing in this subsection shall be construed to preclude the use, by a qualified practitioner, of training received pursuant to this subsection to satisfy registration requirements of a State or for some other lawful purpose. In this section: The term first applicable registration means the first registration or renewal of registration by a qualified practitioner under this section that occurs on or after the date that is 180 days after the date of enactment of the Restoring Hope for Mental Health and Well-Being Act of 2022. In this subsection, the term qualified practitioner means a practitioner who— is licensed under State law to prescribe controlled substances; and is not solely a veterinarian. .
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 263
Requiring prescribers of controlled substances to complete training
Cites 1Cited by 0 across 0 sources